🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Toripalimab

Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer NCT06525428Phase 21 site📍 Shanghai Fudan University · Tests: standard systemic therapy combined with high/low-dose radiotherapy plus toripalimab Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 NCT06028672NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: Toripalimab, Actinomycin-D Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma NCT04778956Phase 37 sites📍 Guangzhou📍 Guangzhou📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, salvage surgery Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. NCT06705127Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: TORIPALIMAB INJECTION(JS001 ), Stereotactic Body Radiation Therapy (SBRT) A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours NCT06868199Phase 1, Phase 26 sites📍 Ryde📍 Ryde📍 Wollongong LaNova Medicines Limited · Tests: LM-168, Toripalimab Toripalimab Plus FLOT in Locally Advanced Gastric Cancer NCT04891016Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: FLOT combined with toripalimab GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. NCT06851247Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, Anlotinib, Gemcitabine, Cisplatin, radiation Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02) NCT06682195Phase 213 sites📍 Nanchang📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Neoadjuvant chemotherapy combined with Toripalimab A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors NCT06117566Phase 1, Phase 21 site📍 Changchun Shanghai Jiatan Pharmatech Co., Ltd · Tests: WX390, Toripalimab Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial NCT06965231Phase 24 sites📍 Shanghai📍 Shanghai📍 Shanghai Fudan University · Tests: Toripalimab combined with Endostar Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer NCT06671262Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: SBRT, Immuno-chemotherapy Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC NCT07088211Phase 21 site📍 Shanghai Shanghai Ninth People's Hospital Affiliated to Shanghai Jia… · Tests: Sacituzumab Tirumotecan and Toripalimab TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma NCT06912711Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, Nimotuzumab, surgery Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression NCT06269211Phase 22 sites📍 Guangzhou📍 Shanghai Ruijin Hospital · Tests: Toripalimab Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma NCT04453813Phase 36 sites📍 Guangzhou📍 Guangzhou📍 Shaoguan Sun Yat-sen University · Tests: Toripalimab plus concurrent chemo-radiotherapy, Concurrent chemo-radiotherapy Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma NCT06151743Phase 21 site📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: three cycles (toripalimab + cetuximab + platinum), Radical surgery, Radiotherapy or chemoradiotherapy To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer NCT06389006Phase 21 site📍 Shanghai RemeGen Co., Ltd. · Tests: Disitamab Vedotin for Injection, Toripalimab, Epirubicin, Cyclophosphamide Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04) NCT06977893Phase 313 sites📍 Hangzhou📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Neoadjuvant Chemotherapy in Combination with Toripalimab, Neoadjuvant Chemotherapy PDT For Induction Therapy For Head And Neck Cancer NCT07214987Phase 22 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Toripalimab-tpzi, Cisplatin, Docetaxel Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) NCT06437977Phase 31 site📍 Shanghai Shanghai Chest Hospital · Tests: SBRT, Toripalimab A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144Phase 130 sites📍 Tucson📍 Duarte📍 Aurora Coherus Oncology, Inc. · Tests: CHS-114, Toripalimab, 5 Fluorouracil, Cisplatin Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors NCT07625423Phase 11 site📍 Chengdu West China Hospital · Tests: EDS01 1.0×10^11 VP + Toripalimab, EDS01 5.0×10^11 VP + Toripalimab, EDS01 1.0×10^12 VP + Toripalimab IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors NCT07508761Phase 1, Phase 21 site📍 Shanghai Nanjing Immunophage Biotech Co., Ltd · Tests: IPG7236, Toripalimab Injection Toripalimab Combined With Definitive CCRT for LACC Patients NCT06256224NA1 site📍 Shanghai Ruijin Hospital · Tests: Toripalimab, CCRT Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study NCT06547203Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cetuximab, Toripalimab, Irinotecan Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial NCT07106034Phase 21 site📍 Shanghai Shanghai Pudong Hospital · Tests: Ongericimab + Toripalimab + Bevacizumab + FOLFOX, Ongericimab + Toripalimab + Bevacizumab + FOLFIRI Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases NCT07277322Phase 1, Phase 21 site📍 New York Dan Feng · Tests: Dupilumab, Toripalimab Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites📍 Chengdu📍 Chengdu📍 Chengdu West China Hospital · Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer NCT07353723Phase 21 site📍 Shanxi Tang-Du Hospital · Tests: Nimotuzumab, Toripalimab, Nab-paclitaxel, carboplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy